The frequency of an inactivating point mutation (566C → T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4338-4343

  Jiang, Min ^a   Aittomäki, Kristiina ^b   Nilsson, Christel ^a   Pakarinen, Pirjo ^a   Iitiä, Antti ^a   Torresani, Toni ^d   Simonsen, Henrik ^e   Goh, Victor ^f   Pettersson, Kim ^a   De La Chapelle, Albert ^c,g   Huhtaniemi, Ilpo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Folkhälson Inst of Genetics   (Finland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e STATENS SERUM INSTITUT   (Denmark)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; DEOXYCYTIDINE; EUROPIUM; FOLLITROPIN; FOLLITROPIN RECEPTOR; LYSINE;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE INFERTILITY; FINLAND; FLUOROMETRY; GENE INACTIVATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HYPERGONADOTROPIC HYPOGONADISM; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MUTATION RATE; NEWBORN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RECEPTOR GENE; SPERMATOGENESIS;

EID: 0032452410     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.12.4338     Document Type: Article

References (37)

1. 1. Aittomäki K, Dieguez Lucena JL, Pakarinen P, et al. 1995 Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 82:959-968.
2. 2. Aittomäki K. 1994 The genetics of XX donadal dysgenesis. Am J Hum Genet. 54:844-851.
3. 3. Aittomäki K, Herva R, Stenman U-H, et al. 1996 Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab. 81:3722-3726.
4. 4. Tapanainen JS, Aittomäki K, Jiang M, Vaskivuo T, Huhtaniemi IT. 1997 Men homozygous for an inactivaing mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatagenesis and fertility. Nat Genet. 15:205-206.
5. 5. Riordan J, Rommens J, Kerem B, et al. 1989 Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245:1066-1073.
6. 6. Landegren U, Kaiser R, Sander J, Hood L. 1988 A ligase-mediated gene detection technique. Science. 241:1077-1080.
7. 7. Wu D, Wallac B. 1989 Specificity of nick-closing activity of bacteriophage T4 DNA ligase. Gene. 76:245-254.
8. 8. Gibbs R, Nguyen P, Caskey C. 1989 Detection of single base differences by competitive oligonucleotide priming. Nucleic Acids Res. 17:2437-2448.
9. 1-antitrypsin deficiency: application of an improved method for amplifying mutated gene sequences. Lab Invest. 59:403-408.
10. 10. Newton C, Graham A, Heptinstall L, et al. 1989 Analysis of any point mutation in DNA. The amplification refractory mutation system. Nucleic Acids Res. 17:2503-2516.
11. 11. Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich H, Arnheim N. 1985 Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1350-1354.
12. 12. Gibbs RA, Nguyen PH, McBride LJ, Koepf SM, Caskey CT. 1989 Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. Proc Natl Acad Sci USA. 86:1919-23.
13. 13. Syvänen A, Ikonen E, Manninen T, Bengström M, Söderlund H, Aula P, Peltonen L. 1992 Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to asparty-glucosaminuria in Finland. Genomics. 12:590-595.
14. 1-antitrypsin deficiency. Clin Chem. 39:1626-1631.
15. 15. Dahlén P, Iitiä AJ, Skagius G, Frostell A, Nunn MF, Kwiatkowski M. 1991 Detection of human immunodeficiency virus type 1 by using the polymerase chain reaction and a time-resolved fluorescence-based hybridization assay. J Clin Microbiol. 29:798-804.
16. 16. Heinonen P, Iitiä A, Torresani T, Lövgren T. 1997 Simple triple-label detection of seven cystic fibrosis mutations by time-resolved fluorometry. Clin Chem. 43:1142-1150.
17. 17. Iitiä A, Høgdall E, Dahlén P, Hurskainen P, Vuust J, Siitari H. 1992 Detection of mutation ΔF508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. PCR Methods Appl. 2:157-162.
18. 18. Nørgaard-Pedersen B, Høgdall E, Iitiä A, Arends J, Dahlén P, Vuust J. 1993 Immunoreactive trypsin and a comparison of two ΔF508 mutation analyses in newborn screening for cystic fibrosis: an anonymous pilot study in Denmark. Screening. 2:1-11.
19. 19. Iitiä A, Liukkonen L Siitari H. 1992 Simultaneous detection of two cystic fibrosis alleles using dual-label time-resolved fluorometry. Mol Cell Probes. 6:505-512.
20. 20. Iitiä A, Mikola M, Gregersen N, Hurskainen P, Lövgren T. 1994 Detection of a point mutation using short oligonucleotide probes in allele-specific hybridization. Biotechniques. 17:566-573.
21. 21. Seddon HR, Gray G, Pollitt RJ, Iitiä A, Green A. 1997 Population screening for the common G985 mutation causing medium-chain acyl-CoA dehydrogenase deficiency with Eu-labeled oligonucleotides and DELFIA system. Clin Chem. 43:436-442.
22. 22. Soini E, Lövgren T. 1987 Time-resolved fluorescence of lanthanide probes and application in biotechnology. Crit Rev Anal Chem. 18:105-154.
23. 23. Hurskainen P, Dahlén P, Siitari H, Lövgren T. 1990 Time-resolved fluorometry: principles and application to clinical microbiology and DNA probe technology. Adv Exp Med Biol. 263:123-130.
24. 24. Higuchi R. 1989 Simple and rapid preparation of samples for PCR. In: Erlich HA, ed. PCR technology: principles and applications for DNA amplification. New York: Stockton Press; 31-38.
25. 25. Kawasaki ES. 1990 PCR protocols: A guide to methods and applications: preparation of DNA from white blood cells or whole blood. San Diego: Academic Press; 148.
26. 26. Sambrook J, Fritsch EF Maniatis T. 1989 Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2.12.1-4.
27. 3+[ρθβ]-labeled oligo DNA hybridization probes. Nucleos Nucleot. 7:655-659.
28. 28. Norio R. 1981 Diseases of Finland and Scandinavia. In: Rotschild H, ed. Biocultural aspects of disease. New York: Academic Press; 359-415.
29. 29. de la Chapelle A. 1993 Diseases gene mapping in isolated human population: the example of Finland. J Med Genet. 30:857-865.
30. 30. Alitalo T, Kruse TA, de la Chapelle A. 1991 Refined localization of the gene causing X linked juvenile retinoschisis. Genomics. 9:505-510.
31. 31. Höglund P, Sistonen P, Norio R, et al. 1995 Fine mapping of the congenital chloride diarrhea gene by linkage disequilibrium. Am J Hum Genet. 57:95-102.
32. 32. Malafosse A, Lehesjoki AE, Genton P, et al. 1992 Identical genetic locus for Baltic and Mediterranean myoclonus. Lancet. 339:1080-1081.
33. 33. Layman LC, Amde S, Cohen DP, Jin M, Xie J. 1998 The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure. Fertil Steril. 69:300-302.
34. 34. Gromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C, Nieschlag E. 1996 Function and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol. 125:177-182.
35. 35. Simoni M, Gromoll J, Nieschlag E. 1997 The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 18:739-773.
36. 36. Conway GS. 1996 Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol (Oxf). 45:657-663.
37. 37. Clayton RN. 1996 Gonadrotrophin receptors. Bailliere Clin Endocrinol Metab. 10:1-8.